loader
Please Wait
Applying Filters...

Looking for Controlled & Modified Release? Find poly dl lactic co glycolic acid for stability, solubility & bioavailability enhancement on PharmaCompass.

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Nomisma Healthcare

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

02

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Brand Name : PLGA

Excipient Details : PLGA (Poly (Lactic-Co-Glycolic Acid)) is a unique base polymer for controlled release of drugs & medical implant materials. It is biodegradable & biocompatible and since both monomers occur naturally it has minimal toxicity.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10.

Grade : Oral, Parenteral

arrow

Brand : PLGA

Applications : PLGA (Poly (Lactic-Co-Glycolic Acid)) is a unique base polymer for controlled release of drugs & medical implant materials. It is biodegradable & biocompatible and since both monomers occur naturally it has minimal toxicity.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10.

Grade : Oral, Parenteral

arrow
blank